200 related articles for article (PubMed ID: 28884432)
21. Validation of FFQ-based assessment of dietary lignans compared with serum enterolactone in Swedish women.
Lin Y; Wolk A; Håkansson N; Peñalvo JL; Lagergren J; Adlercreutz H; Lu Y
Br J Nutr; 2013 May; 109(10):1873-80. PubMed ID: 23006454
[TBL] [Abstract][Full Text] [Related]
22. Determinants of serum enterolactone concentration.
Kilkkinen A; Stumpf K; Pietinen P; Valsta LM; Tapanainen H; Adlercreutz H
Am J Clin Nutr; 2001 Jun; 73(6):1094-100. PubMed ID: 11382665
[TBL] [Abstract][Full Text] [Related]
23. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status.
Zaineddin AK; Vrieling A; Buck K; Becker S; Linseisen J; Flesch-Janys D; Kaaks R; Chang-Claude J
Int J Cancer; 2012 Mar; 130(6):1401-10. PubMed ID: 21544804
[TBL] [Abstract][Full Text] [Related]
24. Plasma enterolignans are associated with lower colorectal adenoma risk.
Kuijsten A; Arts IC; Hollman PC; van't Veer P; Kampman E
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1132-6. PubMed ID: 16775171
[TBL] [Abstract][Full Text] [Related]
25. Use of antibiotics is associated with lower enterolactone plasma concentration.
Bolvig AK; Kyrø C; Nørskov NP; Eriksen AK; Christensen J; Tjønneland A; Knudsen KE; Olsen A
Mol Nutr Food Res; 2016 Dec; 60(12):2712-2721. PubMed ID: 27500753
[TBL] [Abstract][Full Text] [Related]
26. An incident case-referent study on plasma enterolactone and breast cancer risk.
Hultén K; Winkvist A; Lenner P; Johansson R; Adlercreutz H; Hallmans G
Eur J Nutr; 2002 Aug; 41(4):168-76. PubMed ID: 12242585
[TBL] [Abstract][Full Text] [Related]
27. Plasma enterolactone and genistein and the risk of premenopausal breast cancer.
Piller R; Chang-Claude J; Linseisen J
Eur J Cancer Prev; 2006 Jun; 15(3):225-32. PubMed ID: 16679865
[TBL] [Abstract][Full Text] [Related]
28. Prediagnosis plasma concentrations of enterolactone and survival after colorectal cancer: the Danish Diet, Cancer and Health cohort.
Kyrø C; Frederiksen K; Holm M; Nørskov NP; Knudsen KEB; Overvad K; Tjønneland A; Olsen A
Br J Nutr; 2019 Sep; 122(5):552-563. PubMed ID: 30173678
[TBL] [Abstract][Full Text] [Related]
29. Plasma enterolactone and breast cancer risk in the Nurses' Health Study II.
Xie J; Tworoger SS; Franke AA; Terry KL; Rice MS; Rosner BA; Willett WC; Hankinson SE; Eliassen AH
Breast Cancer Res Treat; 2013 Jun; 139(3):801-9. PubMed ID: 23760859
[TBL] [Abstract][Full Text] [Related]
30. Circulating enterolactone and risk of endometrial cancer.
Zeleniuch-Jacquotte A; Lundin E; Micheli A; Koenig KL; Lenner P; Muti P; Shore RE; Johansson I; Krogh V; Lukanova A; Stattin P; Afanasyeva Y; Rinaldi S; Arslan AA; Kaaks R; Berrino F; Hallmans G; Toniolo P; Adlercreutz H
Int J Cancer; 2006 Nov; 119(10):2376-81. PubMed ID: 16929490
[TBL] [Abstract][Full Text] [Related]
31. Plasma enterolactone and incidence of endometrial cancer in a case-cohort study of Danish women.
Aarestrup J; Kyrø C; Knudsen KE; Weiderpass E; Christensen J; Kristensen M; Würtz AM; Johnsen NF; Overvad K; Tjønneland A; Olsen A
Br J Nutr; 2013 Jun; 109(12):2269-75. PubMed ID: 23114205
[TBL] [Abstract][Full Text] [Related]
32. Enterolactone glucuronide and β-glucuronidase in antibody directed enzyme prodrug therapy for targeted prostate cancer cell treatment.
Di Y; Ji S; Wolf P; Krol ES; Alcorn J
AAPS PharmSciTech; 2017 Aug; 18(6):2336-2345. PubMed ID: 28116598
[TBL] [Abstract][Full Text] [Related]
33. Variation in fasting and non-fasting serum enterolactone concentrations in women of the Malmö Diet and Cancer cohort.
Sonestedt E; Ericson U; Gullberg B; Peñalvo JL; Adlercreutz H; Wirfält E
Eur J Clin Nutr; 2008 Aug; 62(8):1005-9. PubMed ID: 17538540
[TBL] [Abstract][Full Text] [Related]
34. Serum enterolactone concentration and the risk of coronary heart disease in a case-cohort study of Finnish male smokers.
Kilkkinen A; Erlund I; Virtanen MJ; Alfthan G; Ariniemi K; Virtamo J
Am J Epidemiol; 2006 Apr; 163(8):687-93. PubMed ID: 16510545
[TBL] [Abstract][Full Text] [Related]
35. Intake of lignans is associated with serum enterolactone concentration in Finnish men and women.
Kilkkinen A; Valsta LM; Virtamo J; Stumpf K; Adlercreutz H; Pietinen P
J Nutr; 2003 Jun; 133(6):1830-3. PubMed ID: 12771325
[TBL] [Abstract][Full Text] [Related]
36. Plasma alkylresorcinol metabolites as biomarkers for whole-grain intake and their association with prostate cancer: a Swedish nested case-control study.
Drake I; Sonestedt E; Gullberg B; Bjartell A; Olsson H; Adlercreutz H; Tikkanen MJ; Wirfält E; Wallström P
Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):73-83. PubMed ID: 24220909
[TBL] [Abstract][Full Text] [Related]
37. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
[TBL] [Abstract][Full Text] [Related]
38. Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis.
Seibold P; Vrieling A; Johnson TS; Buck K; Behrens S; Kaaks R; Linseisen J; Obi N; Heinz J; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Aug; 135(4):923-33. PubMed ID: 24436155
[TBL] [Abstract][Full Text] [Related]
39. Plasma metabolite abundances are associated with urinary enterolactone excretion in healthy participants on controlled diets.
Miles FL; Navarro SL; Schwarz Y; Gu H; Djukovic D; Randolph TW; Shojaie A; Kratz M; Hullar MAJ; Lampe PD; Neuhouser ML; Raftery D; Lampe JW
Food Funct; 2017 Sep; 8(9):3209-3218. PubMed ID: 28808723
[TBL] [Abstract][Full Text] [Related]
40. Mammalian phytoestrogens: enterodiol and enterolactone.
Wang LQ
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Sep; 777(1-2):289-309. PubMed ID: 12270221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
